The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Direct Stimulation of T Cells by Type I IFN Enhances the CD8+ T Cell Response during Cross-Priming
Open accessAbstract
Type I IFN (IFN-αβ), which is produced rapidly in response to infection, plays a key role in innate immunity and also acts as a stimulus for the adaptive immune response. We have investigated how IFN-αβ induces cross-priming, comparing CD8+ T cell responses generated against soluble protein Ags in the presence or absence of IFN-αβ. Injection of IFN-α was found to prolong the proliferation and expansion of Ag-specific CD8+ T cells, which was associated with marked up-regulation of IL-2 and IL-15 receptors on Ag-specific cells and expression of IL-15 in the draining lymph node. Surprisingly, neither IL-2 nor IL-15 was required for IFN-α-induced cross-priming. Conversely, expression of the IFN-αβR by T cells was shown to be necessary for effective stimulation of the response by IFN-α. The finding that T cells represent direct targets of IFN-αβ-mediated stimulation reveals an additional mechanism by which the innate response to infection promotes adaptive immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
T cell receptor antagonist peptides induce positive selection
Hogquist, K. A., Jameson, S. C., Heath, W. R., Howard, J. L., Bevan, M. J., & Carbone, F. R. (1994) · Cell · doi:10.1016/0092-8674(94)90169-4 · Cited by 2,858
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions
Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R., & Melief, C. J. M. (1998) · Nature · doi:10.1038/31002 · Cited by 2,615
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
Ridge, J. P., Di Rosa, F., & Matzinger, P. (1998) · Nature · doi:10.1038/30989 · Cited by 2,342
Help for cytotoxic-T-cell responses is mediated by CD40 signalling
Bennett, S. R. M., Carbone, F. R., Karamalis, F., Flavell, R. A., Miller, J. F. A. P., & Heath, W. R. (1998) · Nature · doi:10.1038/30996 · Cited by 2,092
Hornung, V., Rothenfusser, S., Britsch, S., Krug, A., Jahrsdörfer, B., Giese, T., Endres, S., & Hartmann, G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4531 · Cited by 1,935
Jung, S., Unutmaz, D., Wong, P., Sano, G.-I., De los Santos, K., Sparwasser, T., Wu, S., Vuthoori, S., Ko, K., Zavala, F., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00365-5 · Cited by 1,773
Cd8+ but Not Cd8− Dendritic Cells Cross-Prime Cytotoxic T Cells in Vivo
den Haan, J. M. M., Lehar, S. M., & Bevan, M. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.12.1685 · Cited by 1,328
Potent and Selective Stimulation of Memory-Phenotype CD8+ T Cells In Vivo by IL-15
Zhang, X., Sun, S., Hwang, I., Tough, D. F., & Sprent, J. (1998) · Immunity · doi:10.1016/s1074-7613(00)80564-6 · Cited by 1,245
Self-citationGu, H., Zou, Y.-R., & Rajewsky, K. (1993) · Cell · doi:10.1016/0092-8674(93)90644-6 · Cited by 989
Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures
Goodbourn, S., Didcock, L., & Randall, R. E. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-10-2341 · Cited by 977
Bevan, M. J. (1976) · The Journal of experimental medicine · doi:10.1084/jem.143.5.1283 · Cited by 956
Toll-like receptor 3 promotes cross-priming to virus-infected cells
Schulz, O., Diebold, S. S., Chen, M., Näslund, T. I., Nolte, M. A., Alexopoulou, L., Azuma, Y.-T., Flavell, R. A., Liljeström, P., & Reis e Sousa, C. (2005) · Nature · doi:10.1038/nature03326 · Cited by 921
IL-15Rα Recycles and Presents IL-15 In trans to Neighboring Cells
Dubois, S., Mariner, J., Waldmann, T. A., & Tagaya, Y. (2002) · Immunity · doi:10.1016/s1074-7613(02)00429-6 · Cited by 913
Turnover of naive- and memory-phenotype T cells.
Tough, D. F., & Sprent, J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1127 · Cited by 869
Self-citationCross-priming of CD8+ T cells stimulated by virus-induced type I interferon
Le Bon, A., Etchart, N., Rossmann, C., Ashton, M., Hou, S., Gewert, D., Borrow, P., & Tough, D. F. (2003) · Nature Immunology · doi:10.1038/ni978 · Cited by 818
Self-citationType I Interferons Keep Activated T Cells Alive
Marrack, P., Kappler, J., & Mitchell, T. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.521 · Cited by 759
Bennett, S. R. M., Carbone, F. R., Karamalis, F., Miller, J. F. A. P., & Heath, W. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.1.65 · Cited by 725
B lymphocyte-specific, Cre-mediated mutagenesis in mice
Rickert, R. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.6.1317 · Cited by 718
Kurts, C., Kosaka, H., Carbone, F. R., Miller, J. F. A. P., & Heath, W. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.239 · Cited by 706
Interleukin 15 Is Required for Proliferative Renewal of Virus-specific Memory CD8 T Cells
Becker, T. C., Wherry, E. J., Boone, D., Murali-Krishna, K., Antia, R., Ma, A., & Ahmed, R. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020369 · Cited by 683
Curtsinger, J. M., Valenzuela, J. O., Agarwal, P., Lins, D., & Mescher, M. F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4465 · Cited by 630
Sigal, L. J., Crotty, S., Andino, R., & Rock, K. L. (1999) · Nature · doi:10.1038/18038 · Cited by 578
Schluns, K. S., Williams, K., Ma, A., Zheng, X. X., & Lefrançois, L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.4827 · Cited by 521
Differential Production of IL-12, IFN-α, and IFN-γ by Mouse Dendritic Cell Subsets
Hochrein, H., Shortman, K., Vremec, D., Scott, B., Hertzog, P., & O’Keeffe, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5448 · Cited by 490
Immune Tolerance After Delivery of Dying Cells to Dendritic Cells In Situ
Liu, K., Iyoda, T., Saternus, M., Kimura, Y., Inaba, K., & Steinman, R. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021215 · Cited by 468
Belz, G. T., Behrens, G. M. N., Smith, C. M., Miller, J. F. A. P., Jones, C., Lejon, K., Fathman, C. G., Mueller, S. N., Shortman, K., Carbone, F. R., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020861 · Cited by 467
Immune Responses in Interleukin-2-Deficient Mice
Kündig, T. M., Schorle, H., Bachmann, M. F., Hengartner, H., Zinkernagel, R. M., & Horak, I. (1993) · Science · doi:10.1126/science.8235625 · Cited by 462
Mattei, F., Schiavoni, G., Belardelli, F., & Tough, D. F. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1179 · Cited by 459
Self-citationTherapeutic use of IL-2 to enhance antiviral T-cell responses in vivo
Blattman, J. N., Grayson, J. M., Wherry, E. J., Kaech, S. M., Smith, K. A., & Ahmed, R. (2003) · Nature Medicine · doi:10.1038/nm866 · Cited by 396
Cellular mechanisms governing cross-presentation of exogenous antigens
Ackerman, A. L., & Cresswell, P. (2004) · Nature Immunology · doi:10.1038/ni1082 · Cited by 393
Burkett, P. R., Koka, R., Chien, M., Chai, S., Boone, D. L., & Ma, A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041389 · Cited by 392
Toll-Like Receptor Ligands Directly Promote Activated CD4+ T Cell Survival
Gelman, A. E., Zhang, J., Choi, Y., & Turka, L. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6065 · Cited by 386
Type I Interferon-mediated Stimulation of T Cells by CpG DNA
Sun, S., Zhang, X., Tough, D. F., & Sprent, J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2335 · Cited by 361
Self-citationIL-15 Promotes the Survival of Naive and Memory Phenotype CD8+ T Cells
Berard, M., Brandt, K., Paus, S. B., & Tough, D. F. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.5018 · Cited by 343
Self-citationInactivation of Notch1 in immature thymocytes does not perturb CD4 or CD8 T cell development
Wolfer, A., Bakker, T., Wilson, A., Nicolas, M., Ioannidis, V., Littman, D. R., Wilson, C. B., Held, W., MacDonald, H. R., & Radtke, F. (2001) · Nature Immunology · doi:10.1038/85294 · Cited by 300
Matikainen, S., Sareneva, T., Ronni, T., Lehtonen, A., Koskinen, P. J., & Julkunen, I. (1999) · Blood · doi:10.1182/blood.v93.6.1980.406k20_1980_1991 · Cited by 278
IL-2 Is Not Required for the Initiation of CD8 T Cell Cycling but Sustains Expansion
D’Souza, W. N., & Lefrançois, L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.5727 · Cited by 237
Kneitz, B., Herrmann, T., Yonehara, S., & Schimpl, A. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250925 · Cited by 229
Interferon‐β mediates stromal cell rescue of T cells from apoptosis
Pilling, D., Akbar, A. N., Girdlestone, J., Orteu, C. H., Borthwick, N., Amft, N., Scheel‐Toellner, D., Buckley, C. D., & Salmon, M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199903)29:03<1041::aid-immu1041>3.0.co;2-# · Cited by 195
Type I Interferon as a Link Between Innate and Adaptive Immunity through Dendritic Cell Stimulation
TOUGH, D. F. (2004) · Leukemia & Lymphoma · doi:10.1080/1042819031000149368 · Cited by 189
Self-citationMueller, S. N., Jones, C. M., Smith, C. M., Heath, W. R., & Carbone, F. R. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20012023 · Cited by 188
Cutting Edge: Dendritic Cells Are Sufficient to Cross-Present Self-Antigens to CD8 T Cells In Vivo
Kurts, C., Cannarile, M., Klebba, I., & Brocker, T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.1439 · Cited by 184
Cousens, L. P., Orange, J. S., & Biron, C. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.12.5690 · Cited by 176
Sandau, M. M., Schluns, K. S., Lefrancois, L., & Jameson, S. C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6537 · Cited by 175
IFN-α and IL-12 Induce IL-18 Receptor Gene Expression in Human NK and T Cells
Sareneva, T., Julkunen, I., & Matikainen, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.1933 · Cited by 171
Antiproliferative action of interferon-α requires components of T-cell-receptor signalling
Petricoin, E. F., Ito, S., Williams, B. L., Audet, S. A., Stancato, L. F., Gamero, A. M., Clouse, K. A., Grimley, P. M., Weiss, A., Beeler, J. A., et al. (1997) · Nature · doi:10.1038/37648 · Cited by 150
Cheng, L. E., Öhlén, C., Nelson, B. H., & Greenberg, P. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052676899 · Cited by 128
IL-15 augments CD8+ T cell-mediated immunity against Toxoplasma gondii infection in mice
Khan, I. A., & Kasper, L. H. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.2103 · Cited by 125
Villinger, F. J., Miller, R., Mori, K., Mayne, A. E., Boštík, P., Sundstrom, J. B., Sugimoto, C., & Ansari, A. A. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.07.022 · Cited by 101
Interferons, a group of multiple lymphokines
Kirchner, H. (1984) · Springer Seminars in Immunopathology · doi:10.1007/bf00201966 · Cited by 100
Kaser, A., Nagata, S., & Tilg, H. (1999) · Cytokine · doi:10.1006/cyto.1998.0484 · Cited by 96
Rubinstein, M. P., Kadima, A. N., Salem, M. L., Nguyen, C. L., Gillanders, W. E., & Cole, D. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.4928 · Cited by 91
IFN-α regulates IL-21 and IL-21R expression in human NK and T cells
Strengell, M., Julkunen, I., & Matikainen, S. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1003488 · Cited by 73
Down-Modulation of Responses to Type I IFN Upon T Cell Activation
Dondi, E., Rogge, L., Lutfalla, G., Uzé, G., & Pellegrini, S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.2.749 · Cited by 69
Listeria -Infected Myeloid Dendritic Cells Produce IFN-β, Priming T Cell Activation
Feng, H., Zhang, D., Palliser, D., Zhu, P., Cai, S., Schlesinger, A., Maliszewski, L. E., & Lieberman, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.421 · Cited by 69
Opposing Effects of IL-2 in Tumor Immunotherapy: Promoting CD8 T Cell Growth and Inducing Apoptosis
Shrikant, P. A., & Mescher, M. F. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.1753 · Cited by 65
IFN-α2b Reduces IL-2 Production and IL-2 Receptor Function in Primary CD4+ T Cells
Zella, D., Romerio, F., Curreli, S., Secchiero, P., Cicala, C., Zagury, D., & Gallo, R. C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2296 · Cited by 41
Holáň, V., Kohno, K., & Minowada, J. (1991) · Journal of Interferon Research · doi:10.1089/jir.1991.11.319 · Cited by 30
Bi-phasic Effect of Interferon (IFN)-α
Eriksen, K. W., Sommer, V. H., Woetmann, A., Rasmussen, A. B., Brender, C., Svejgaard, A., Skov, S., Geisler, C., & Ødum, N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m310472200 · Cited by 25
Utermöhlen, O., Tárnok, A., Bönig, L., & Lehmann-Grube, F. (1994) · European Journal of Immunology · doi:10.1002/eji.1830241227 · Cited by 15
Cited by
Type I interferons in infectious disease
McNab, F., Mayer-Barber, K., Sher, A., Wack, A., & O'Garra, A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3787 · Cited by 2,780
Type I interferon is selectively required by dendritic cells for immune rejection of tumors
Diamond, M. S., Kinder, M., Matsushita, H., Mashayekhi, M., Dunn, G. P., Archambault, J. M., Lee, H., Arthur, C. D., White, J. M., Kalinke, U., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101158 · Cited by 1,081
Self-citationType I Interferon in Systemic Lupus Erythematosus and Other Autoimmune Diseases
Banchereau, J., & Pascual, V. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.010 · Cited by 963
Inflammatory cytokines as a third signal for T cell activation
Curtsinger, J. M., & Mescher, M. F. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.02.013 · Cited by 615
Cancer Immunotherapy by Dendritic Cells
Melief, C. J. M. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.004 · Cited by 508
Metadata
- Authors
- Le Bon, A., Durand, V., Kamphuis, E., Thompson, C., Bulfone-Paus, S., Rossmann, C., Kalinke, U., & Tough, D. F.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-04
- Volume
- 176
- Issue
- 8
- Pages
- 4682-4689
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1522207028
- Cited by
- 283
- References
- 60
- FWCI
- 7.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.